IC
MRNA icon

IEQ Capital’s Moderna MRNA Stock Holding History

IEQ Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,795
Closed -$215K – 1996
2025
Q2 		$215K Buy
+7,795
New +$205K ﹤0.01% 1580
2025
Q1 		– Sell
-7,194
Closed -$299K – 1688
2024
Q4 		$299K Buy
+7,194
New +$344K ﹤0.01% 1027
2024
Q3 		– Sell
-15,998
Closed -$1.9M – 1185
2024
Q2 		$1.9M Buy
15,998
+5,668
+55% +$717K 0.03% 351
2024
Q1 		$1.1M Buy
10,330
+1,637
+19% +$165K 0.02% 442
2023
Q4 		$865K Buy
8,693
+3,326
+62% +$280K 0.01% 458
2023
Q3 		$554K Sell
5,367
-1,359
-20% -$152K 0.01% 538
2023
Q2 		$817K Sell
6,726
-1,969
-23% -$263K 0.02% 442
2023
Q1 		$1.34M Buy
8,695
+608
+8% +$100K 0.03% 330
2022
Q4 		$1.45M Sell
8,087
-2,207
-21% -$361K 0.04% 296
2022
Q3 		$1.22M Buy
10,294
+3,859
+60% +$586K 0.03% 321
2022
Q2 		$919K Buy
6,435
+38
+0.6% +$5.43K 0.03% 323
2022
Q1 		$1.1M Buy
6,397
+917
+17% +$154K 0.03% 313
2021
Q4 		$1.39M Sell
5,480
-400
-7% -$117K 0.03% 251
2021
Q3 		$2.26M Buy
5,880
+2,622
+80% +$967K 0.06% 167
2021
Q2 		$766K Buy
3,258
+1,122
+53% +$201K 0.02% 291
2021
Q1 		$280K Buy
+2,136
New +$310K 0.01% 378
2020
Q4 		– Sell
-2,875
Closed -$203K – 328
2020
Q3 		$203K Buy
+2,875
New +$200K 0.01% 365

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

IEQ Capital's MRNA Position: Q3 2025 in Review

IEQ Capital sold out of Moderna (MRNA) in Q3 2025, closing a stake of 7,795 shares — an estimated $215K sold.

IEQ Capital first reported a position in MRNA in Q3 2020 and held it in 17 quarters. The position peaked at $2.26M in Q3 2021. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • IEQ Capital reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • IEQ Capital sold 7,795 Moderna shares in Q3 2025, an estimated $215K.
  • IEQ Capital first reported a position in Moderna in Q3 2020 and held it in 17 quarters.
  • IEQ Capital's Moderna position peaked at $2.26M in Q3 2021.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on IEQ Capital's 13F filing for Q3 2025, filed 14 Nov 2025.